Cite
HARVARD Citation
Hofman, M. et al. (n.d.). TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU international. pp. 5-13. [Online].